Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Apyx Medical (APYX) Leases (2019 - 2025)

Apyx Medical's Leases history spans 10 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Leases rose 8687.5% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, up 8687.5%, while the annual FY2025 figure was $4.2 million, 8687.5% up from the prior year.
  • Leases reached $4.2 million in Q4 2025 per APYX's latest filing, down from $4.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $5.2 million in Q4 2023 to a low of $38000.0 in Q2 2025.
  • Average Leases over 5 years is $1.7 million, with a median of $179000.0 recorded in 2021.
  • The largest YoY upside for Leases was 8687.5% in 2025 against a maximum downside of 99.23% in 2025.
  • A 5-year view of Leases shows it stood at $121000.0 in 2021, then fell by 4.96% to $115000.0 in 2022, then skyrocketed by 4388.7% to $5.2 million in 2023, then tumbled by 99.07% to $48000.0 in 2024, then skyrocketed by 8687.5% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Leases are $4.2 million (Q4 2025), $4.3 million (Q3 2025), and $38000.0 (Q2 2025).